New-onset impulse control disorders after treatment with levodopa-carbidopa intestinal gel in Parkinson's disease

Neurologia (Engl Ed). 2023 Apr;38(3):220-221. doi: 10.1016/j.nrleng.2022.04.002.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Carbidopa / adverse effects
  • Disruptive, Impulse Control, and Conduct Disorders* / drug therapy
  • Humans
  • Levodopa / adverse effects
  • Parkinson Disease* / drug therapy

Substances

  • Levodopa
  • Carbidopa
  • Antiparkinson Agents